Meeting Abstract, 2024

Blocking the IL-22RA1 improves the molecular and histological signature of Atopic Dermatitis-insights from in vivo and in vitro AD models

EXPERIMENTAL DERMATOLOGY, ISSN 0906-6705, Volume 33, 3,

Contributors

Wasserer, S. [1] Litman, T. [2] Hebsgaard, J. [2] Jargosch, M. [1] Pilz, A. [3] Garzorz-Stark, N. [1] Biedermann, T. [1] Blanchetot, C. [4] Mortensen, M. Sidsel [2] Skak-Nielsen, T. [2] Bertelsen, M. [2] Eyerich, K. [3] Lauffer, F. [1] Martel, B. [2] Eyerich, S. [5] [6]

Affiliations

  1. [1] Tech Univ Munich, Dept Dermatol & Allergy, D-80802 Munich, Germany
    2. [NORA names: Germany; Europe, EU; OECD];
  2. [2] LEO Pharma AS, Ballerup, Denmark
    3. [NORA names: LEO Pharma; Private Research; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Univ Freiburg, Dept Dermatol & Allergy, Freiburg, Germany
    4. [NORA names: Germany; Europe, EU; OECD];
  4. [4] Argenx BVBA, Zwijnaarde, Belgium
    5. [NORA names: Belgium; Europe, EU; OECD];
  5. [5] Helmholtz Ctr, Ctr Allergy & Environm, Munich, Germany
    6. [NORA names: Germany; Europe, EU; OECD];

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

  • No Matches Found

SUBJECTS
+

METRICS
+